Corporate GlaxoSmithKline Pharmaceuticals Limited May 13, 2026 GlaxoSmithKline Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |SUBJECT: Outcome of Board Meeting Post navigation Hind Rectifiers Limited Raj Oil Mills Limited Related Posts Nectar Lifesciences Limited Nectar Lifesciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further,… March 1, 2026 Gokaldas Exports Limited Gokaldas Exports Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of… April 21, 2026 Samvardhana Motherson International Limited Samvardhana Motherson International Limited has informed the Exchange that Record date for the purpose of… March 19, 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Nectar Lifesciences Limited Nectar Lifesciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further,… March 1, 2026
Gokaldas Exports Limited Gokaldas Exports Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of… April 21, 2026
Samvardhana Motherson International Limited Samvardhana Motherson International Limited has informed the Exchange that Record date for the purpose of… March 19, 2026
